Press Releases Adaptive Biotechnologies Corporation

Stocks

ADPT

US00650F1093

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:20:59 2026-06-11 pm EDT			5-day change	1st Jan Change
18.82 ^USD	+10.25%		+4.20%	+16.01%

May. 29	Adaptive Biotechnologies Corporation Reports New Data Reinforcing Pivotal Role of clonoSEQ MRD Testing Across Hematology Clinical Practice and Research	CI
May. 12	Morgan Stanley Lowers Price Target on Adaptive Biotechnologies to $18 From $21, Keeps Equalweight Rating	MT

Press Releases

May. 29	At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research	GL
May. 21	Adaptive Biotechnologies to Participate in Upcoming Investor Conferences	GL
May. 05	Adaptive Biotechnologies : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
May. 05	Adaptive Biotechnologies : Q1 2026 earnings deck Final	PU
May. 05	Adaptive Biotechnologies: Q1 Earnings Snapshot	AQ
May. 05	Adaptive Biotechnologies Reports First Quarter 2026 Financial Results	GL
Apr. 15	Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026	GL
Mar. 24	Adaptive Biotechnologies : 2026 Adaptive Investor Presentation (278910)	PU
Feb. 05	Adaptive Biotechnologies : ADPT 4Q25 Earnings Slides	PU
Feb. 05	Adaptive Biotechnologies: Q4 Earnings Snapshot	AQ
Feb. 05	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results	GL
Feb. 05	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
Jan. 27	Adaptive Biotechnologies to Participate in Upcoming Investor Conferences	GL
Jan. 22	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026	GL
Jan. 12	Adaptive Biotechnologies : ADPT JPM Presentation	PU
Jan. 12	Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results	GL
Dec. 30	Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference	GL
Dec. 15	Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer	GL
Dec. 09	Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease	GL
Dec. 06	Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting	GL
Nov. 25	Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ MRD Testing across a Range of Blood Cancers to be presented at the 67th ASH Annual Meeting	AQ
Nov. 24	Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting	GL
Nov. 06	Adaptive Biotechnologies to Participate in Upcoming Investor Conferences	GL
Nov. 05	Adaptive Biotechnologies: Q3 Earnings Snapshot	AQ
Nov. 05	Adaptive Biotechnologies : ADPT 3Q25 Earnings Deck	PU